Caffey disease is a rare genetic condition that causes painful swelling of the soft tissues and new bone growth in infants. Early symptoms of Caffey disease often start in the first months of life and include irritability, fever, and tender, firm areas over the jaw, arms, or legs. Many babies with Caffey disease improve over weeks to months, and most recover without long-term problems. Treatment for Caffey disease focuses on comfort with pain relievers and careful monitoring, and some need short courses of anti-inflammatory medicines. The outlook is usually good, and deaths are very uncommon.
Overview
Caffey diseaseSymptoms
Caffey disease usually appears in early infancy with sudden painful swelling over bones, most often the jaw, arms, or legs. Babies may be irritable and feverish, and the affected area feels warm and tender. Doctors see thickened bone on imaging.
Outlook and prognosis
Most babies with Caffey disease improve over months as swelling and bone changes settle, and growth returns to a typical pace. Pain flares can happen but usually ease with supportive care. Long-term complications are uncommon, though rare bone thickening may persist.
Causes and risk factors
Caffey disease usually results from a change in a collagen gene, often new but sometimes inherited in a dominant way. A parent with the variant raises risk. Environmental or lifestyle factors aren’t primary causes; illness may trigger flares.
Genetic influences
Genetics play a central role in Caffey disease. Most cases stem from a single gene change in COL1A1 that affects collagen, often inherited in an autosomal dominant pattern. Variants can influence age at onset, severity, and whether episodes recur.
Diagnosis
Doctors diagnose Caffey disease by the pattern of painful bone swelling in infants, supported by X‑rays showing outer bone thickening. Blood tests assess inflammation and rule out infection or injury. Genetic diagnosis of Caffey disease uses COL1A1 testing to confirm.
Treatment and drugs
Treatment for Caffey disease focuses on comfort and protecting bones during flare-ups. Doctors often use short courses of anti‑inflammatory medicines for pain and swelling, monitor feeding and growth, and guide gentle activity. Genetic counseling and regular follow‑up help families plan care.
Symptoms
For families, the first signs are often firm swelling over a bone, tenderness, and a baby who seems unusually fussy or hard to settle. In medical terms, this is infantile cortical hyperostosis; in everyday life, it shows up as puffy, sometimes warm areas over the jaw, collarbone, or the long bones of the arms and legs. People often notice early features of Caffey disease within the first months of life, and these can include brief fevers, reduced movement of the sore limb, and feeding trouble if the jaw is involved.
Firm, raised swelling develops over affected bones, most often the lower jaw, collarbone, or long bones. The area can look puffy and feel warm to the touch.
Swelling of the lower jaw can make opening the mouth uncomfortable. Babies with Caffey disease may drool more, refuse the bottle or breast, or cry with feeding. The lower face may look fuller on one side.
Soreness of the bone and nearby tissues can make a baby unusually fussy. Touching or moving the area may trigger crying, and soothing may take longer than usual.
Short fevers may occur even without a cold or other infection. In Caffey disease, these fevers often come and go as the swelling flares.
How people usually first notice Caffey disease?
Many families first notice something is off when a very young baby becomes unusually irritable and tender to touch, with warm, swollen areas on the face or limbs that seem painful without a clear injury. Doctors often confirm these first signs of Caffey disease with an X‑ray showing new, thickened bone along the jaw, collarbone, or long bones, and sometimes a fever adds to the confusion with infection. These early clues—painful soft‑tissue swelling and rapid, localized bone thickening—are the classic first signs of Caffey disease, or how Caffey disease is first noticed in infancy.
Types of Caffey disease
Caffey disease is a rare genetic bone condition that can look a little different from one family to another. Broadly, symptoms are grouped into a classic infant form and a later‑onset or familial form, both linked to changes in the COL1A1 gene that affect how early bone forms. Early symptoms of Caffey disease often include irritability, swelling over the jaw or long bones, and warmth or tenderness in those areas, while later forms can be milder or come and go. Not everyone will experience every type.
Infantile form
This classic type starts in the first months of life with painful, warm swelling over the jaw, collarbone, or long bones. Babies may be fussy, feed less, or have a low‑grade fever during flares. Swelling usually settles over months and bones remodel with time.
Familial variant
This inherited form can appear later in infancy or childhood and may run in families with a known COL1A1 change. Episodes of bone swelling tend to be milder, shorter, and may recur. Growth is often normal between episodes.
Prenatal‑onset form
Rarely, changes are seen before birth on ultrasound as thickened bones. Newborns may have breathing or feeding challenges if the chest or jaw is involved. Severity ranges widely and some features improve after birth.
What genetics can tell you about symptoms
Some babies with Caffey disease who carry a COL1A1 gene change develop painful, swollen soft spots on the jaw, collarbone, or limbs, along with fever and irritability. This variant alters type I collagen, making bone layers overgrow and tissues inflame during flare-ups.
Causes and risk factors
Caffey disease is most often caused by a change in the COL1A1 gene, which affects type I collagen. This change can be inherited from a parent or can arise as a new mutation in the child. Having a gene change doesn’t mean you’ll definitely develop the condition. Family history is the main risk factor, while lifestyle and everyday environment do not seem to add much risk. Illness or certain medicines can mimic or temporarily worsen bone inflammation, so knowing your family history can help you act quickly if early symptoms of Caffey disease appear.
Environmental and biological risk factors
Risk factors for Caffey disease mainly come from inside the body and start before birth. Doctors often group risks into internal (biological) and external (environmental). At this time, environmental risk factors for Caffey disease are not clearly defined. Research has not shown consistent links with infections, toxins, or routine pregnancy exposures.
Changes that arise during early development in the womb appear to drive most cases of Caffey disease. These built‑in factors are present at birth and set the underlying likelihood.
No specific exposures such as radiation, heavy metals, or air pollution have been consistently linked to Caffey disease. Avoiding harmful exposures remains wise for general pregnancy health.
Common infections during pregnancy have not been shown to raise the risk. Treating infections promptly still helps protect overall maternal–fetal well‑being.
There is no evidence that labor, delivery method, or short‑term birth stress changes the chance of this condition. Standard newborn care does not alter whether it occurs.
Genetic risk factors
In most families, Caffey disease traces back to a single change in the COL1A1 gene that helps build type I collagen in bone. The genetic causes of Caffey disease are typically inherited in an autosomal dominant way, with symptoms varying widely between relatives, and some cases arise as brand-new (de novo) changes. Carrying a genetic change doesn’t guarantee the condition will appear.
COL1A1 gene variant: Most cases involve a recurrent change in the COL1A1 gene that affects type I collagen. This disrupts how bone forms and remodels in early life.
Autosomal dominant inheritance: One altered copy of the gene can be enough to cause Caffey disease. Each child of an affected parent has a 50% chance of inheriting the change.
Variable expressivity: Features and timing can vary widely, even within the same family. Some infants have marked swelling and irritability, while others show only mild bone changes on imaging.
Reduced penetrance: Not everyone who inherits the change develops noticeable signs. This can make family history appear skipped in some generations.
De novo mutation: In some children, the gene change occurs for the first time and is not found in either parent. In these situations, the risk to brothers and sisters is usually low.
Parental mosaicism: Rarely, a parent carries the change in only a portion of their cells, which standard blood tests may miss. This can increase the chance of another affected child despite negative parental testing.
Collagen-related overlap: The same gene is linked to other collagen conditions, but different variants lead to different outcomes. Family history of a related condition does not automatically raise risk without the specific Caffey-related change.
Lifestyle risk factors
Caffey disease is a genetic condition; lifestyle habits do not cause it, but day‑to‑day routines can meaningfully influence pain, mobility, and comfort. Understanding how lifestyle affects Caffey disease helps families support recovery during flare-ups. Below are practical lifestyle risk factors for Caffey disease—factors that can worsen or ease symptoms depending on how they’re managed.
Adequate vitamin D and balanced infant nutrition support healthy bone remodeling during flare-ups. Over-supplementing calcium or vitamin D without clinician guidance can cause problems without improving hyperostosis. Follow pediatric dosing to avoid gastrointestinal upset that can worsen discomfort.
Light, pain-limited range-of-motion helps maintain joint flexibility when swelling restricts mobility. Overvigorous exercise or prolonged tummy time during painful flares can increase irritability and guarding. Short, frequent sessions guided by your clinician are safest.
Supportive positioning can reduce pressure on tender bones and soften pain. Rough handling or frequent lifting under the affected limb may aggravate swelling. Teach all caregivers the same handling plan.
Consistent naps and bedtime can reduce pain sensitization and fussiness during active disease. Irregular sleep may amplify pain perception and make feeding and therapy harder. Use soothing strategies approved by your clinician.
Risk prevention
Caffey disease is a genetic condition, so there’s no way to fully prevent it, but you can lower the chance of flares causing problems and support healthy development. Learning the early symptoms of Caffey disease—like new, tender swelling over a bone with fussiness and fever—and acting promptly can help. Different people need different prevention strategies—there’s no single formula. Planning ahead with your care team can reduce stress and avoid unnecessary tests or procedures.
If Caffey disease runs in your family, a genetics visit can explain inheritance and chances for future children. They can review testing options and what results may mean for your family.
When a family mutation is known, some families consider prenatal or embryo testing to inform planning. Your genetics team can discuss benefits, limits, and timing.
Learn the early symptoms of Caffey disease so you can seek care quickly. Prompt evaluation can ease pain sooner and may prevent unnecessary biopsies or antibiotics.
Ask your doctor for a written plan for pain and fever medicines. Starting treatment at the first signs of swelling can reduce discomfort and help your child stay active.
Transmission
Caffey disease (also called infantile cortical hyperostosis) is not contagious; it can’t be caught or spread through everyday contact, coughing, sex, pregnancy, or breastfeeding.
Caffey disease is genetic and most often follows an autosomal dominant pattern—one changed copy of a gene is enough to cause it. If a parent has Caffey disease, each child has a 50% chance of inheriting it, yet many babies are the first in the family because the change happened for the first time in that child. When both parents are unaffected, the chance of another child with Caffey disease is usually low, though rarely a parent may carry the change in a small number of eggs or sperm without symptoms; a genetics professional can explain how Caffey disease is inherited and discuss testing options.
When to test your genes
Consider genetic testing if a baby has unexplained painful swelling of bones with cortical thickening on X‑ray, especially if episodes recur or start in infancy. Testing is also reasonable when there’s a family history of early‑onset bone overgrowth consistent with Caffey disease. Results can confirm the diagnosis, guide pain management, and inform family planning.
Diagnosis
Parents often first notice a firm, tender swelling over a baby’s jaw or limb along with fussiness and low fever. Many people feel relief just knowing what’s really going on. The diagnosis of Caffey disease is usually made by combining a careful exam with imaging and a few blood tests, and then confirmed if needed with genetic testing. Doctors also check for other causes that can look similar in infants.
Doctors ask about when swellings started, any fever or feeding changes, and family history. They examine which bones are affected, often noticing the jaw and long bones.
Standard X-rays look for characteristic thickening of the outer bone layer along the shafts of long bones and the mandible. These patterns help distinguish Caffey disease from infection or injury.
Basic labs often show signs of inflammation, such as raised markers and alkaline phosphatase. Results support the picture but do not make the diagnosis on their own.
Ultrasound can show new bone forming under the covering of the bone (periosteum) without radiation. It is especially useful in very young infants and in follow-up.
Stages of Caffey disease
Caffey disease does not have defined progression stages. It usually appears in early infancy with sudden swelling and irritability, then settles over weeks to months, so it behaves more like a flare that heals rather than a step-by-step decline. Doctors look at early symptoms of Caffey disease together with a physical exam and X-rays; sometimes blood tests and, in select cases, genetic testing for a known collagen gene change help confirm the picture. Many people feel reassured knowing what their tests can—and can’t—show.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially when Caffey disease shows up in infancy with painful, swollen bones and irritability. The reassuring big picture is that most babies with Caffey disease improve over months as the active phase settles, and long-term health is usually good. Doctors call this the prognosis—a medical word for likely outcomes. Some children may have brief flare-ups or lingering thickened bone on scans, but everyday activities like crawling, walking, and play typically progress on schedule once pain eases.
Looking at the long-term picture can be helpful. For most families, early symptoms of Caffey disease peak in the first few months and fade during the first year or two, and serious complications are uncommon. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. A known inherited form linked to a COL1A1 gene change can run in families, yet severity still varies; not everyone with the same gene change will have the same outlook. Mortality is rare in modern care, and when problems do arise, they’re usually tied to severe swelling in limited areas or to other medical conditions happening at the same time.
With ongoing care, many people maintain normal growth and development after the active phase ends. Regular check-ins help manage pain early, track bone changes, and spot any uncommon issues with the jaw, ribs, or limbs that might affect feeding or movement. Ask about early warning signs and what steps to take if they appear. Talk with your doctor about what your personal outlook might look like, including how your child’s specific pattern, family history, and any genetic results may guide expectations over time.
Long-term effects
Caffey disease usually flares in infancy and then quiets down, with most children growing up without lasting problems. Long-term effects vary widely, and many have none at all. A small number may have lingering bone thickening or subtle changes in the jaw or limbs that affect appearance or movement. Rarely, episodes return later in childhood, but this is uncommon.
Many children have no lasting issues once the infant phase passes. Early symptoms of Caffey disease often resolve by age 1–2.
Some previously affected bones stay a bit thicker or denser. This is often only seen on X-rays and causes no problems.
Overgrowth of the lower jaw can persist in some. This may leave a prominent chin or bite alignment differences.
Past inflammation can leave mild bowing or small limb-length differences. For most, walking, running, and play are not limited.
How is it to live with Caffey disease?
Living with Caffey disease often means navigating periods of pain, fussiness, and swelling in the jaw, arms, or legs during infancy, with sleep and feeding sometimes disrupted until flare-ups settle. Daily life for caregivers can involve frequent soothing, pain management as advised by the care team, and regular check-ins to monitor bone changes, which can feel exhausting but is usually time-limited since most children improve significantly over months to a few years. For siblings and family, routines may shift around appointments and comfort measures, yet many families find a steady rhythm and see symptoms ease with time. As children grow, most return to typical activities, and long-term outlook is generally reassuring.
Treatment and drugs
Caffey disease treatment focuses on easing pain and swelling during flares and supporting comfort while the condition runs its course, since symptoms usually improve on their own over months. Doctors often use pain relievers like acetaminophen or ibuprofen, and in tougher cases may prescribe short courses of anti‑inflammatory medicines such as corticosteroids to calm bone and soft‑tissue inflammation. If a baby has trouble feeding or moving because of jaw or limb pain, gentle physical therapy, positioning, and feeding support can help daily routines feel easier. Although living with Caffey disease can feel overwhelming, many people manage their symptoms and live fulfilling lives. Most children recover fully, but your doctor may suggest follow‑up visits and imaging to track healing and adjust medicines if needed.
Non-drug treatment
Swelling and tenderness can make everyday care—feeding, dressing, and sleep—feel challenging for families. Alongside medicines, non-drug therapies can ease discomfort, protect movement, and support feeding while Caffey disease runs its course. Most approaches focus on gentle handling, comfort measures, and keeping joints moving without pain. Care teams adjust plans as babies grow and symptoms change.
Use soft supports to keep the swollen area cushioned and elevated when possible. Avoid pressure on tender limbs or jaw. Change positions regularly to prevent stiffness.
Gentle range-of-motion keeps joints flexible without pushing into pain. Short, frequent sessions help maintain movement and comfort. Therapists teach safe exercises you can do at home.
Techniques for soothing, handling, and dressing reduce strain on tender areas. Therapists can suggest adaptive tools for bathing or clothing. They also help build routines that fit your baby’s energy.
If the jaw is sore, try softer nipples, paced feeds, or different holding positions. A lactation or feeding specialist can tailor strategies to protect comfort and nutrition. This can prevent long feeds that tire your baby.
Your genes may have an impact on how drugs work for you
Medicines used for Caffey disease, like pain relievers or anti‑inflammatory drugs, can work differently depending on gene variants that affect how your liver processes them. Pharmacogenetic testing may help tailor dose and choice, reducing side effects while maintaining relief.
Pharmacological treatments
Caffey disease often settles on its own, so medicines focus on easing pain, swelling, and fussiness so babies can feed and sleep better. Drugs that target symptoms directly are called symptomatic treatments. Doctors usually start with simple pain relievers and anti-inflammatory drugs, and may use a short course of steroids for severe flares. The aim is comfort and function while the bone changes calm down.
Eases pain and fever tied to Caffey disease and is often the first option. It’s generally well tolerated when dosed by weight; avoid exceeding the daily maximum to protect the liver. Ask your doctor why a specific drug was recommended for you.
Reduce swelling and bone pain, including during early symptoms of Caffey disease when tenderness and irritability peak. Some medicines work quickly, while others may take a few doses to build effect. Give with food and watch for stomach upset or reduced appetite.
Used short term for severe swelling, jaw involvement, or poor feeding that doesn’t improve with NSAIDs. Dosing may be increased or lowered gradually to find the lowest effective amount. Short tapers help limit side effects like sleep changes or moodiness.
Helps protect the stomach if longer NSAID or steroid use is needed for Caffey disease. Can lower the risk of irritation, reflux, or bleeding. Your clinician will weigh benefits and risks for your child.
Genetic influences
In many families, Caffey disease is linked to a single gene change that affects collagen, a key protein that supports bones and connective tissue. This change can be inherited from a parent who carries it, or it can appear for the first time in a child even when both parents are healthy. Having a gene change doesn’t always mean you will develop the condition. Because the same change can lead to different severities even within one family, a clear family pattern can be strong, faint, or absent. When doctors consider genetic testing for Caffey disease, they are usually looking for a known collagen‑gene variant; a positive result can confirm the cause and guide counseling for future pregnancies. If testing is negative, Caffey disease can still be diagnosed based on clinical features, since not every case has an identifiable gene change yet.
Is Caffey disease genetic?
Genetics play a central role in Caffey disease. Most cases stem from a single gene change in COL1A1 that affects collagen, often inherited in an autosomal dominant pattern. Variants can influence age at onset, severity, and whether episodes recur.
Pharmacogenetics—how genetics influence drug effects
For Caffey disease, treatment focuses on easing pain and swelling, most often with anti-inflammatory pain relievers and, during tough flares, short courses of steroids. A change in a collagen gene (often called COL1A1) explains many cases; confirming this early when doctors see early symptoms of Caffey disease can set expectations and reduce unnecessary tests. Genetic testing can sometimes identify how your body processes certain anti-inflammatory medicines, which may help doctors choose a dose that works with fewer side effects. Differences in liver enzymes can make some people clear these drugs more slowly, so a lower dose or a different option may be safer to protect the stomach and limit bleeding risk. Because codeine and similar opioids rely on another enzyme to become active, children who convert them very quickly can have dangerous side effects; in the US and EU these medicines are generally avoided in young children, and any pharmacogenetic results, if available, reinforce that choice. The COL1A1 change itself doesn’t usually dictate which medicines treat Caffey disease, but it does clarify the diagnosis, inform family counseling, and supports a careful, symptom-based plan.
Interactions with other conditions
Day-to-day, the early symptoms of Caffey disease—fever, fussiness, and tender, swollen bones—can look a lot like an infection, which can lead to confusion with illnesses such as osteomyelitis. Doctors call it a “comorbidity” when two conditions occur together, and in practice the bigger challenge is telling them apart so infants don’t receive unnecessary antibiotics or invasive tests meant for bone infections. Caffey disease also overlaps with other collagen-related conditions in how the body’s support tissue is built; while having both is uncommon, shared collagen pathways mean families with a history of brittle bones or stretchy joints should mention this to their care team. Another real-world interaction appears in babies with congenital heart disease who receive prostaglandin E1: this medicine can cause a temporary form of cortical bone thickening that mimics Caffey disease, so heart and bone teams often coordinate to adjust treatment and watch symptoms closely. When pain medicines or short courses of steroids are used for Caffey disease, clinicians will weigh infection risks and stomach side effects, especially if a child is being evaluated for an illness that also causes fever. With careful care, many people live well despite having both a rare bone condition and another health issue, but getting the diagnosis right is the key step that guides safe treatment.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies with strikingly swollen jaws and limbs who later improved on their own. Families and midwives noticed that an otherwise healthy infant might become fussy, warm to the touch, and develop firm, tender swellings along the lower face or forearms—only to see these changes fade months later. In some communities, elders recalled a “hard jaw” phase that several relatives had experienced in infancy, hinting at a family pattern long before science caught up.
First described in the medical literature as infantile cortical hyperostosis, the condition now widely known as Caffey disease was initially recognized through these visible features: painful, firm swellings over bones and a jaw that looked unusually prominent. Early doctors documented fevers, irritability, and difficulty feeding, then watched as the bone changes settled with time. From early written records to modern studies, observers noted the same arc—rapid onset in infancy, a stormy few weeks to months, and gradual recovery.
As medical science evolved, X‑rays revealed that the outer layer of certain bones became thicker during flare‑ups, explaining the ridges and swellings parents felt. Over time, descriptions became more precise, separating Caffey disease from infections or injuries that can look similar in a crying, feverish infant. Clinicians learned that most episodes start in the first months of life, often affect the jaw and forearms, and tend to resolve without lasting problems, though some bone thickening can linger.
Advances in genetics later connected many familial cases to a change in a collagen gene that helps give bone its structure. This finding supported what generations had noticed—Caffey disease can run in families—and clarified why the condition can vary, even within the same family. Today, historical case notes and newer genetic studies together shape our understanding: Caffey disease often announces itself suddenly in early infancy, follows a recognizable course, and, for many, quiets down as quickly as it came.